Search results
Results From The WOW.Com Content Network
Those profits were also due in part to Mylan's continually raising the price of EpiPens starting in 2009: in 2007, the wholesale price of two EpiPens was about $100; the price was about the same in 2009; by July 2013, the price was about $265; in May 2015, it was around $461; and in May 2016, the price rose again to around $609, [28] around a ...
For premium support please call: 800-290-4726 more ways to reach us
Those profits were also due in part to Mylan's continually raising the price of EpiPens starting in 2009; in 2009 the wholesale price of two EpiPens was about $100, by July 2013 the price was about $265, in May 2015 it was around $461, and in May 2016 the price rose again to around $609, [90] around a 500% jump from the price in 2009. [94]
The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has been approved by the Food and Drug Administration to treat anaphylaxis.. Neffy, a nasal spray that ...
Neffy is expected to be available in eight weeks, per ARS Pharma, which would put its release sometime in the fall. Parikh is excited to see what the device will do for patients with severe allergies.
The Center for Surveillance, Epidemiology and Laboratory Services (CSELS) is a branch of the US Centers for Disease Control and Prevention (CDC) that provides scientific service, expertise, skills, and tools in support of national efforts to promote health; prevent disease, injury and disability; and prepare for emerging health threats. [1]
Construction Data Company, is a publisher of business information which caters to the commercial construction industry. They are also known as CDC News and CDC Publishing, and are the third largest provider of commercial SaaS construction reports in the United States, next to Dodge Report and Reed Construction Data. They supply construction ...
The Centers for Medicare & Medicaid Services confirmed to lawmakers that the drug company that makes EpiPen, has been overcharging the government. CONFIRMED: The maker of EpiPen overcharged the ...